NDC81284-0315-05: INDIGOTINDISULFONATE SODIUM INJE.
INDIGOTINDISULFONATE SODIUM INJE. Key specifications include administration: INTRAVENOUS, primary_container_type: AMPUL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 5.0 MILLILITERS, part_name_assigned_by_controlling_agency: INDIGOTINDISULFONATE SODIUM INJECTION, 5 ML AMPULE, 5S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-696-3155, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| primary_container_type | AMPUL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 5 |
| primary_container_content_quantity | 5.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | INDIGOTINDISULFONATE SODIUM INJECTION, 5 ML AMPULE, 5S |
| NSN | 6505-01-696-3155 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.0 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | AMPUL |
| SPECIAL FEATURES | EMPLOYED AS A KIDNEY FUNCTION TEST; FOR INTRAVENOUS USE; PACKAGE OF 5 AMPULES; STRENGTH: 0.8% SOLUTION; STORE AT 20 TO 25 C (68 TO 77 F); EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); PROTECT FROM LIGHT; DO NOT REFRIGERATE OR FREEZE. DRUG PRODUCT IS FDA APPROVED. FOR INTRAVENOUS USE ONLY. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | INDIGOTINDISULFONATE SODIUM INJECTION, 5 ML AMPULE, 5S |
| TOTAL PRIMARY CONTAINER QUANTITY | 5 |